Medical devices in Bulgaria: Regulatory framework, market dynamics, and institutional development
Open Access
- 27 April 2026
- journal article
- Published by Pensoft Publishers in Pharmacia
- Vol. 73
Abstract
Bulgaria occupies a unique position among European Union member states, with the lowest per capita healthcare expenditure (€990 annually) yet demonstrating the second-highest growth rate in health spending between 2014 and 2022. This economic paradox reflects the dynamics of a developing market operating under resource constraints while facing growing needs from an aging population. The medical devices sector is an essential component of Bulgaria‘s healthcare system, including products ranging from simple consumables to sophisticated implantable devices and advanced diagnostic equipment. This review examines the Bulgarian medical device landscape through multiple dimensions: historical evolution from medieval surgical instruments to contemporary AI-integrated systems, fundamental distinctions from pharmaceuticals and dietary supplements based on mechanisms of action, the comprehensive regulatory framework under Medical Device Regilation (MDR) 2017/745, institutional interactions among key organizations (the Bulgarian Drug Agency, the National Health Insurance Fund, the Ministry of Health), and market trends shaped by demographic transformation. With a population of 6.44 million (23.8% over 65 years), Bulgaria faces pressing demographic challenges that reshape healthcare demand patterns. The analysis reveals a market exceeding €300 million, dependent on imports (>90%), with limited domestic manufacturing capacity. Despite the financial constraints, Bulgaria has achieved an international recognition through top-tier regulatory inspections and active participation in the European regulatory structures. The review outlines perspectives for short-term priorities (2025–2027), medium-term objectives (2027–2030), and long-term vision (2030+) for sector development, emphasizing the digital transformation, regional coverage improvement, and demographic crisis management through the technological innovation.Keywords
This publication has 25 references indexed in Scilit:
- The Origins of Regulations for Pharmaceutical Products and Medical Devices – What Can be Learned for the Governance of Medical Devices in Europe?European Review, 2025
- Joseph Lister (1827-1912): Surgeon, Scientist, Pathologist, and Founding Father of Antiseptic SurgeryUrology, 2024
- Biomechanical and functional efficacy of knee sleeves: A literature reviewPhysical Therapy in Sport, 2017
- PRICING, REIMBURSEMENT, AND HEALTH TECHNOLOGY ASSESSMENT OF MEDICINAL PRODUCTS IN BULGARIAInternational Journal of Technology Assessment in Health Care, 2017
- Combined Treatment With Chondroitin Sulfate and Glucosamine Sulfate Shows No Superiority Over Placebo for Reduction of Joint Pain and Functional Impairment in Patients With Knee Osteoarthritis: A Six‐Month Multicenter, Randomized, Double‐Blind, Placebo‐Controlled Clinical TrialArthritis & Rheumatology, 2016
- Preferences of Bulgarian consumers for quality, access and price attributes of healthcare services-result of a discrete choice experimentThe International Journal of Health Planning and Management, 2015
- Ambroise Paré IV: The early history of artificial limbs (from robotic to prostheses)International Orthopaedics, 2013
- Ambroise Paré II: Paré’s contributions to amputation and ligatureInternational Orthopaedics, 2013
- De Humani Corporis FabricaSurgical RevolutionJournal of Investigative Surgery, 2008
- Reforming health care financing in Bulgaria: the population perspectiveSocial Science & Medicine, 2004